tiprankstipranks
Hepion Pharmaceuticals (HEPA)
:HEPA
US Market

Hepion Pharmaceuticals (HEPA) Income Statement

Compare
740 Followers

Hepion Pharmaceuticals Income Statement

Last quarter (Q3 2024), Hepion Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Hepion Pharmaceuticals's net income was $-4.87M. See Hepion Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -67.13K$ -77.46K$ -86.07K$ -34.52K$ -26.74K
Operating Expenses
$ 48.45M$ 43.62M$ 30.40M$ 20.15M$ 7.77M
Depreciation and Amortization
$ 67.13K$ 77.46K$ 86.07K$ 34.52K$ 26.74K
EBITDA
$ -49.26M$ -43.54M$ -30.32M$ -20.11M$ -7.74M
Operating Income
$ -48.45M$ -45.49M$ -30.40M$ -20.15M$ -7.77M
Other Income/Expenses
$ -887.11K$ 404.83K$ -2.32M$ -177.28K$ -175.94K
Pretax Income
$ -49.34M$ -45.08M$ -32.72M$ -20.32M$ -7.95M
Net Income
$ -48.93M$ -42.20M$ -32.72M$ -20.35M$ -7.04M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -12.32$ -11.07$ -9.31$ -42.06$ -68.88
Diluted EPS
$ -12.32$ -11.07$ -9.31$ -42.06$ -68.88
Weighted Average Shares Outstanding
3.97M 3.81M 3.51M 483.89K 102.16K
Weighted Average Shares Outstanding (Diluted)
3.97M 3.81M 3.51M 483.89K 102.16K
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis